This Is the Investment Case for Legalised Cannabis Markets
Whether you are opposed to their presence of not, legalised cannabis markets are here to stay.
In April, Pennsylvanina become the 24th state to approve cannabis for medical purposes in the US, while it is already legal to all over-21s in four states and Washington DC.
In the same month, Germany joined a host of European countries in creating medical cannabis legislation. Further afield, Australia, Uruguay and Brazil announced cannabis programmes last year and Canada is transitioning from a medical regime to a full adult-use market.
Some suggest the legal cannabis market could reach $50bn in raw cannabis sales within ten years, others suggest figures closer to $300bn.
If processed and cannabinoid-based pharmaceutical products are included, the market is potentially much larger.
Whatever the forecasts, we are only at the beginning – the size of the market opportunity is immense, with a market growth rate approaching triple digits.
As a...
This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.
Follow us on Instagram
Connect with us on Linkedin